Where to invest $5,000 into ASX growth shares now

These shares could be destined for big things according to analysts.

| More on:
happy investor, share price rise, increase, up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you've got $5,000 burning a hole in your brokerage account, it could pay to invest it into high-quality ASX growth shares.

But which shares could be good options for these funds right now?

Listed below are three standout ASX growth shares that analysts are currently tipping as buys. Here's what you need to know about them:

NextDC Ltd (ASX: NXT)

The first ASX growth share to look at is NextDC. It is a leading pure-play data centre operator.

As the digital economy continues to expand, driven by cloud computing, artificial intelligence, and enterprise digitisation, demand for reliable, secure and scalable data infrastructure is booming. That's exactly what NextDC provides.

The company is currently executing an ambitious expansion strategy, building out its next generation of hyperscale data centres in Sydney, Melbourne and the Asia-Pacific region. While this involves upfront capital expenditure, management has a track record of delivering long-term value — and locking in blue-chip clients along the way.

With recurring revenue, strong customer retention, and exposure to one of the fastest-growing segments in tech, NextDC could be a smart long-term addition for growth-focused investors.

Goldman Sachs currently rates the company as a buy with a $16.50 price target.

Pro Medicus Ltd (ASX: PME)

Pro Medicus could be another ASX growth share to buy with the funds. It is the medical imaging software powerhouse that has taken the US healthcare sector by storm.

The company's flagship platform, Visage, allows radiologists to view and diagnose images faster and more efficiently — saving time, money, and ultimately lives. What's especially compelling is the quality of the business model: it is capital-light, extremely high-margin, and underpinned by long-term, annuity-style contracts with top-tier US hospital groups.

Goldman Sachs is also feeling very bullish on Pro Medicus and recently put a buy rating and $309.00 price target on its shares.

WiseTech Global Ltd (ASX: WTC)

Last but not least is WiseTech. It is the global leader in logistics software.

Its flagship product, CargoWise, is used by many of the world's largest freight forwarders and logistics companies to manage their supply chains. In a world still grappling with disrupted trade routes and increasing complexity, WiseTech offers critical, mission-essential infrastructure.

What stands out is the company's recurring revenue engine, global scalability, and ability to integrate bolt-on acquisitions. This has allowed WiseTech to consistently deliver double-digit earnings growth in recent years.

Earlier this month, Morgan Stanley put an overweight rating and $140.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Nextdc, Pro Medicus, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »

A man sees some good news on his phone and gives a little cheer.
Growth Shares

5 incredible ASX growth stocks to buy for 2026

These growth stocks could be well-positioned for the long-term.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Growth Shares

These 2 ASX growth shares are ideal for Australians!

These businesses could be much bigger in a decade!

Read more »